Designed a customizable suite of dashboards and reports with robust data analytics and industry benchmarks to generate a 6-month pay back time on solution, 75% reduction in ad-hoc report TAT for employers, and $4K Rx savings per script for HIV patients.
West coast in-home care payvider ❯
Comprehensive support for your top value-based care priorities
MedeAnalytics helps payers gain self-service visibility into drivers of cost and quality, allowing them to transform their relationship with clients and impact on population health management. With the ability to track, trend and drill down into root causes, payers can understand where there are opportunities to combat some of today’s biggest challenges. These include:
- Management of value-based care programs
- High treatment costs
- Ineffective identification of at-risk members
- Unnecessary hospital utilization
- Provider negotiations
- Lack of transparency with employers
- Population health and quality management
Go further: Explore our Payer Value Analytics solutions
Talk with our experts about the power of analytics
Get our take on industry trends
Why “good” isn’t good enough: The hidden cost of sub-4 Star Medicare Advantage performance
Healthcare outcomes have never mattered more, and achieving exceptional performance has never been harder. Many mid-to-large health plans are below the 4-Star threshold in Medicare Advantage (MA).…
Read on...From conversation to coordination: Key takeaways from OpsIgnite 2026
OpsIgnite 2026 brought together operational leaders from across the Blues ecosystem for four days of candid conversation, practical insights, and…
Read on...You have the insights, converting them into measurable action is the challenge: Becker’s takeaways on the next phase of payer performance
The 2026 Becker’s Spring Payer Issues Roundtable brought together more than 500 executives for two days of focused discussion on…
Read on...The gap between insight and performance: What our Becker’s webinar revealed
Healthcare payers are operating under sustained margin pressure. Rising specialty drug costs, post-COVID utilization shifts, Medicaid and Medicare Advantage margin…
Read on...